Sign in
CMPS Stock Price, Chart, Stats & News
COMPASS Pathways plc
Save
1.30B
Market cap
–
Current P/E
–
Forward P/E
CMPS chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -3.76% |
ROA | -136.85% |
ROE | -335.93% |
D/E | -0.66x |
Interest coverage ratio | -39.71x |
CMPS valuation
P/E | – |
P/S | – |
P/B | -9.51x |
P/CF | -3.20x |
P/FCF | -3.28x |
P/OCF | -3.20x |
PEG | 0.13x |
EV multiple | -2.67x |
About
COMPASS Pathways plc is a mental healthcare company with a primary presence in the United Kingdom and the United States. Established in 2020 and headquartered in London, UK, the firm focuses on developing novel treatments. Its key product is COMP360, an investigational psilocybin therapy.
Similar securities
Based on sector and market capitalization
Report issue